These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11991383)

  • 41. All patients with hemodynamically tolerated postinfarction ventricular tachycardia do not require an implantable cardioverter-defibrillator.
    Almendral J; Josephson ME
    Circulation; 2007 Sep; 116(10):1204-12. PubMed ID: 17768304
    [No Abstract]   [Full Text] [Related]  

  • 42. Implantable cardioverter defibrillator detection during radiofrequency catheter ablation of ventricular tachycardia.
    Hammerschmidt S; Cao K; Schaumann A; Krieglstein H; Gonska BD
    Pacing Clin Electrophysiol; 1996 Sep; 19(9):1388-90. PubMed ID: 8880806
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. External implantable defibrillator as a bridge to reimplant after implantable cardioverter-defibrillator explant.
    Dell'Era G; Magnani A; Occhetta E
    Europace; 2015 Nov; 17(11):1726. PubMed ID: 26462698
    [No Abstract]   [Full Text] [Related]  

  • 45. Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site.
    Fetter JG; Benditt DG; Stanton MS
    J Am Coll Cardiol; 1996 Aug; 28(2):423-7. PubMed ID: 8800120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Images in Cardiology: Inappropriate firing of an implantable cardioverter defibrillator due to 60 cycle noise.
    Angella FR; Conti JB; Gonzalez MD; Curtis AB
    Clin Cardiol; 2002 Jun; 25(6):304. PubMed ID: 12058795
    [No Abstract]   [Full Text] [Related]  

  • 47. Multicenter investigation of an implantable cardioverter-defibrillator algorithm to detect oversensing.
    Welte N; Strik M; Eschalier R; Mondoly P; Defaye P; Frontera A; Ritter P; Haïssaguerre M; Ploux S; Koneru J; Ellenbogen KA; Bordachar P
    Heart Rhythm; 2017 Jul; 14(7):1008-1015. PubMed ID: 28323174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tachycardia induction due to inappropriate implantable cardioverter defibrillator therapy: what is the mechanism?
    Tzeis S; Andrikopoulos G; Rassias I; Theodorakis G
    Hellenic J Cardiol; 2010; 51(6):558-62. PubMed ID: 21169192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
    Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
    Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Shock-induced ventricular oversensing due to seal plug damage: a potential mechanism of inappropriate device therapies in implantable cardioverter-defibrillators.
    Cheung JW; Iwai S; Lerman BB; Mittal S
    Heart Rhythm; 2005 Dec; 2(12):1371-5. PubMed ID: 16360095
    [No Abstract]   [Full Text] [Related]  

  • 51. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
    Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
    Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A case of exhaustion of implantable cardioverter defibrillator therapies due to inappropriate programming.
    Fragakis NK; Antoniadis AP; Geleris P
    Hellenic J Cardiol; 2011; 52(4):354-6. PubMed ID: 21933768
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The mean ventricular fibrillation cycle length: a potentially useful parameter for programming implantable cardioverter defibrillators.
    Li H; Easley A; Windle J; Samoil D; Barrington W
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1789-94. PubMed ID: 9744444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Subcutaneous implantable cardioverter-defibrillator: First single-center experience with other cardiac implantable electronic devices.
    Kuschyk J; Stach K; Tülümen E; Rudic B; Liebe V; Schimpf R; Borggrefe M; Röger S
    Heart Rhythm; 2015 Nov; 12(11):2230-8. PubMed ID: 26073595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inappropriate implantable cardioverter defibrillator shocks-incidence, effect, and implications for driver licensing.
    Watanabe E; Okajima K; Shimane A; Ozawa T; Manaka T; Morishima I; Asai T; Takagi M; Honda T; Kasai A; Fujii E; Yamashiro K; Kohno R; Abe H; Noda T; Kurita T; Watanabe S; Ohmori H; Nitta T; Aizawa Y; Kiyono K; Okumura K
    J Interv Card Electrophysiol; 2017 Sep; 49(3):271-280. PubMed ID: 28730420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erroneous discharge of an implantable cardioverter defibrillator caused by an electric razor.
    Seifert T; Block M; Borggrefe M; Breithardt G
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1592-4. PubMed ID: 7479183
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The wearable cardioverter defibrillator as a bridge to implantable defibrillator post myocardial infarction: what do we know?
    Barsheshet A; Vamvouris T; Goldenberg I
    Expert Rev Med Devices; 2016 Jul; 13(7):627-32. PubMed ID: 27333818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review.
    Roston TM; Jones K; Hawkins NM; Bos JM; Schwartz PJ; Perry F; Ackerman MJ; Laksman ZWM; Kaul P; Lieve KVV; Atallah J; Krahn AD; Sanatani S
    Heart Rhythm; 2018 Dec; 15(12):1791-1799. PubMed ID: 30063211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implantable cardioverter defibrillator oversensing: what is the mechanism?
    Vijayaraman P; Ferrell MS; Rhee B; Elam G; Kok LC
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):723-4. PubMed ID: 15175071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.